Medical progress: Polycystic ovary syndrome

[1] Developmental origin of polycystic ovary syndrome - a hypothesis [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 174 (01) : 1 - 5

[2] PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J]. BRITISH MEDICAL JOURNAL, 1986, 293 (6543) : 355 - 359

[3] Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2973 - 2976

[4] American Diabetes Association, 2004, DIABETES CARE S1, V27, pS11, DOI DOI 10.2337/DIACARE.27.2007.S11

[5] A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2434 - 2438

[6] The plasminogen activator system in women with polycystic ovary syndrome [J]. FERTILITY AND STERILITY, 1998, 69 (02) : 236 - 241

[7] Metformin directly inhibits androgen production in human thecal cells [J]. FERTILITY AND STERILITY, 2001, 76 (03) : 517 - 524

[8] Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) : 2317 - 2323

[9] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) : 1626 - 1632

[10] Azziz R, 2000, J PEDIATR ENDOCR MET, V13, P1303

[1] Developmental origin of polycystic ovary syndrome - a hypothesis [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 174 (01) : 1 - 5

[2] PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J]. BRITISH MEDICAL JOURNAL, 1986, 293 (6543) : 355 - 359

[3] Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2973 - 2976

[4] American Diabetes Association, 2004, DIABETES CARE S1, V27, pS11, DOI DOI 10.2337/DIACARE.27.2007.S11

[5] A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2434 - 2438

[6] The plasminogen activator system in women with polycystic ovary syndrome [J]. FERTILITY AND STERILITY, 1998, 69 (02) : 236 - 241

[7] Metformin directly inhibits androgen production in human thecal cells [J]. FERTILITY AND STERILITY, 2001, 76 (03) : 517 - 524

[8] Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) : 2317 - 2323

[9] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) : 1626 - 1632

[10] Azziz R, 2000, J PEDIATR ENDOCR MET, V13, P1303